Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1993-4-8
pubmed:abstractText
The recognition of the acceptor stem of tRNA(Gln) is an important element ensuring the accuracy of aminoacylation by Escherichia coli glutaminyl-tRNA synthetase (GlnRS; EC 6.1.1.18). On the basis of known mutations and the crystal structure of the tRNA(Gln).GlnRS complex, we mutagenized at saturation two motifs in the acceptor end binding domain of GlnRS. Mutants with lowered tRNA specificity were then selected in vivo by suppression of a glutamine-specific amber mutation (lacZ1000) with an amber suppressor tRNA derived from tRNA(1Ser). The mischarging GlnRS mutants obtained in this way retain the ability to charge tRNA(Gln), but in addition, they misacylate a number of noncognate amber suppressor tRNAs. The critical residues responsible for specificity are Arg-130 and Glu-131, located in a part of GlnRS that binds the acceptor stem of tRNA(Gln). On the basis of the spectrum of tRNAs capable of being misacylated by such mutants we propose that, in addition to taking part in productive interactions, the acceptor end binding domain contributes to recognition specificity by rejecting noncognate tRNAs through negative interactions. Analysis of the catalytic properties of one of the mischarging enzymes, GlnRS100 (Arg-130-->Pro, Glu-131-->Asp), indicates that, while the kinetic parameters of the mutant enzyme are not dramatically changed, it binds noncognate tRNA(Glu) more stably than the wild-type enzyme does (Kd is 1/8 that of the wild type). Thus, the stability of the noncognate complex may be the basis for mischarging in vivo.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-1396597, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-1474577, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-1542120, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-1565639, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-16617497, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-1725262, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-1857417, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-1857423, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2047877, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2113914, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2141650, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2199796, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2247608, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2254937, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2452483, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2459391, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2479982, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2673006, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-2686030, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-3045821, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-3144042, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-3881765, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-4341532, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-4564911, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-4585176, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-5803296, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-6288695, http://linkedlifedata.com/resource/pubmed/commentcorrection/7680483-6382258
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
90
pubmed:geneSymbol
glnS
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2010-4
pubmed:dateRevised
2010-9-13
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Acceptor end binding domain interactions ensure correct aminoacylation of transfer RNA.
pubmed:affiliation
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't